Boston Scientific Operating Income increased by 33.5% to $1.10B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.5%, from $921.00M to $1.10B. Over 4 years (FY 2021 to FY 2025), Operating Income shows an upward trend with a 31.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth in operating income suggests that the core business is becoming more profitable and efficient.
The profit realized from a business's own operations after deducting operating expenses like wages, depreciation, and co...
This is a key metric for comparing the fundamental business performance of companies with different tax or debt structures.
operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $262.00M | $387.00M | $180.00M | $466.00M | $423.00M | $358.00M | $402.00M | $552.00M | $514.00M | $693.00M | $584.00M | $675.00M | $520.00M | $733.00M | $675.00M | $921.00M | $819.00M | $1.05B | $825.00M | $1.10B |
| QoQ Change | — | +47.7% | -53.5% | +158.9% | -9.2% | -15.4% | +12.3% | +37.3% | -6.9% | +34.8% | -15.7% | +15.6% | -23.0% | +41.0% | -7.9% | +36.4% | -11.1% | +28.0% | -21.3% | +33.5% |
| YoY Change | — | — | — | — | +61.5% | -7.5% | +123.3% | +18.5% | +21.5% | +93.6% | +45.3% | +22.3% | +1.2% | +5.8% | +15.6% | +36.4% | +57.5% | +43.0% | +22.2% | +19.5% |
| Segment | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 |
|---|---|---|---|---|---|---|---|---|
| Total Allocated To Reportable Segments | $942.00M | $1.01B | $940.00M | $1.01B | $1.02B | $1.13B | $1.27B | $1.35B |
| Total | $358.00M | $402.00M | $552.00M | $514.00M | $693.00M | $675.00M | $520.00M | $733.00M |
Total Allocated To Reportable Segments was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.